Unaudited Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands		Total	Warrants, Reverse Recapitalization	Convertible Notes, Reverse Recapitalization	Convertible Notes, Reverse Recapitalization, Interest Forfeit	Previously Reported	Retroactive application of reverse recapitalization	Series 1 Preferred Stock	Redeemable Convertible Preferred Stock	Series G Preferred Stock	Series H Preferred Stock	Common Stock		Common Stock Warrants, Reverse Recapitalization	Common Stock Convertible Notes, Reverse Recapitalization	Common Stock Previously Reported		Common Stock Retroactive application of reverse recapitalization		Common Stock Redeemable Convertible Preferred Stock	Additional Paid-In Capital	Additional Paid-In Capital Warrants, Reverse Recapitalization	Additional Paid-In Capital Convertible Notes, Reverse Recapitalization	Additional Paid-In Capital Convertible Notes, Reverse Recapitalization, Interest Forfeit	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Retroactive application of reverse recapitalization	Additional Paid-In Capital Redeemable Convertible Preferred Stock	Accumulated Deficit	Accumulated Deficit Previously Reported
Beginning balance at Apr. 24, 2022		$ 52,218				$ 52,218
Beginning balance (in shares) at Apr. 24, 2022	[1]	18,644,339				10,085,612	8,558,727
Increase (Decrease) in Temporary Equity
Issuance of shares (in shares)	[1]									194,104	24,647
Issuance of Redeemable Convertible Preferred Stock, net										$ 1,050	$ 200
Ending balance (in shares) at Jul. 17, 2022	[1]	18,863,090
Ending balance at Jul. 17, 2022		$ 53,468
Shares, beginning balance (in shares) at Apr. 24, 2022												11,400,833				6,167,254		5,234,000
Beginning balance at Apr. 24, 2022		(109,556)				$ (109,556)						$ 1				$ 62		$ (61)			$ 1,711				$ 1,650	$ 61		$ (111,268)	$ (111,268)
Increase (Decrease) in Stockholders' Equity
Net (loss) income		5,035																										5,035
Exercise of stock options (in shares)												2,000
Stock based compensation		52																			52
Shares, ending balance (in shares) at Jul. 17, 2022												11,402,682
Ending balance at Jul. 17, 2022		(104,463)										$ 1									1,769							(106,233)
Increase (Decrease) in Stockholders' Equity
Stock Issued During Period, Value, Stock Options Exercised		6																			6
Beginning balance at Apr. 24, 2022		$ 52,218				$ 52,218
Beginning balance (in shares) at Apr. 24, 2022	[1]	18,644,339				10,085,612	8,558,727
Ending balance (in shares) at Jan. 01, 2023	[1]	18,863,090
Ending balance at Jan. 01, 2023		$ 53,468
Shares, beginning balance (in shares) at Apr. 24, 2022												11,400,833				6,167,254		5,234,000
Beginning balance at Apr. 24, 2022		(109,556)				$ (109,556)						$ 1				$ 62		$ (61)			1,711				1,650	61		(111,268)	(111,268)
Increase (Decrease) in Stockholders' Equity
Net (loss) income		1,253
Reclassification of liability-classified warrants		0
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		0
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		0
Transfer of warrants related to business combination		0
Shares, ending balance (in shares) at Jan. 01, 2023												11,422,477
Ending balance at Jan. 01, 2023		(108,049)										$ 1									1,965							(110,015)
Beginning balance at Jul. 17, 2022		$ 53,468
Beginning balance (in shares) at Jul. 17, 2022	[1]	18,863,090
Ending balance (in shares) at Oct. 09, 2022	[1]	18,863,090
Ending balance at Oct. 09, 2022		$ 53,468
Shares, beginning balance (in shares) at Jul. 17, 2022												11,402,682
Beginning balance at Jul. 17, 2022		(104,463)										$ 1									1,769							(106,233)
Increase (Decrease) in Stockholders' Equity
Net (loss) income		(3,390)																										(3,390)
Issuance of warrants		10																			10
Stock based compensation		59																			59
Shares, ending balance (in shares) at Oct. 09, 2022												11,402,682
Ending balance at Oct. 09, 2022		$ (107,784)										$ 1									1,838							(109,623)
Ending balance (in shares) at Jan. 01, 2023	[1]	18,863,090
Ending balance at Jan. 01, 2023		$ 53,468
Increase (Decrease) in Stockholders' Equity
Net (loss) income		(392)																										(392)
Exercise of stock options (in shares)												20,000
Stock based compensation		67																			67
Shares, ending balance (in shares) at Jan. 01, 2023												11,422,477
Ending balance at Jan. 01, 2023		(108,049)										$ 1									1,965							(110,015)
Increase (Decrease) in Stockholders' Equity
Stock Issued During Period, Value, Stock Options Exercised		60																			60
Beginning balance at Apr. 30, 2023		$ 53,468				$ 53,468				3,550	7,700
Beginning balance (in shares) at Apr. 30, 2023	[1]	18,863,090,000				10,203,945,000	8,659,145,000
Increase (Decrease) in Temporary Equity
Issuance of shares (in shares)	[1]							1,988,620,000
Issuance of Redeemable Convertible Preferred Stock, net								$ 18,463
Accretion of Cumulative Dividends		$ 134
Change in the redemption value of the redeemable convertible preferred stock		1,423
Conversion of cumulative unpaid dividends on Series I redeemable convertible preferred stock to common stock in connection with the reverse recapitalization		$ (878)
Ending balance (in shares) at Jul. 23, 2023	[1]	20,851,710,000
Ending balance at Jul. 23, 2023		$ 73,488
Shares, beginning balance (in shares) at Apr. 30, 2023		11,422,476										11,422,476,000	[1]			6,178,962,000	[1]	5,243,514,000	[1]
Beginning balance at Apr. 30, 2023		$ (114,998)				$ (114,998)						$ 1				$ 62		$ (61)			3,794				3,733	61		(118,793)	(118,793)
Increase (Decrease) in Stockholders' Equity
Net (loss) income		(3,046)																										(3,046)
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		(134)																			(134)
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		(1,423)																			(1,423)
Stock based compensation		141																			141
Shares, ending balance (in shares) at Jul. 23, 2023	[1]											11,422,476,000
Ending balance at Jul. 23, 2023		(119,460)										$ 1									2,378							(121,839)
Beginning balance at Apr. 30, 2023		$ 53,468				$ 53,468				3,550	7,700
Beginning balance (in shares) at Apr. 30, 2023	[1]	18,863,090,000				10,203,945,000	8,659,145,000
Increase (Decrease) in Temporary Equity
Issuance of Redeemable Convertible Preferred Stock, net		$ 19,843
Accretion of Cumulative Dividends		878
Change in the redemption value of the redeemable convertible preferred stock		$ 1,423
Ending balance (in shares) at Jan. 07, 2024	[1]	0
Ending balance at Jan. 07, 2024		$ 0								0	0
Shares, beginning balance (in shares) at Apr. 30, 2023		11,422,476										11,422,476,000	[1]			6,178,962,000	[1]	5,243,514,000	[1]
Beginning balance at Apr. 30, 2023		$ (114,998)				$ (114,998)						$ 1				$ 62		$ (61)			3,794				$ 3,733	$ 61		(118,793)	$ (118,793)
Increase (Decrease) in Stockholders' Equity
Net (loss) income		1,919
Reclassification of liability-classified warrants		$ 940
Exercise of stock options (in shares)		45,177,000
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		$ (878)
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		(1,423)
Transfer of warrants related to business combination		$ 29,824
Shares, ending balance (in shares) at Jan. 07, 2024		39,931,785										39,931,785,000	[1]
Ending balance at Jan. 07, 2024		$ (60,236)										$ 4									56,656							(116,896)
Beginning balance at Jul. 23, 2023		$ 73,488
Beginning balance (in shares) at Jul. 23, 2023	[1]	20,851,710,000
Increase (Decrease) in Temporary Equity
Issuance of shares (in shares)	[1]							138,000,000
Issuance of Redeemable Convertible Preferred Stock, net								$ 1,380
Accretion of Cumulative Dividends		$ 394
Ending balance (in shares) at Oct. 15, 2023	[1]	20,989,710,000
Ending balance at Oct. 15, 2023		$ 75,262
Shares, beginning balance (in shares) at Jul. 23, 2023	[1]											11,422,476,000
Beginning balance at Jul. 23, 2023		(119,460)										$ 1									2,378							(121,839)
Increase (Decrease) in Stockholders' Equity
Net (loss) income		(7,283)																										(7,283)
Issuance of warrants		173																			173
Reclassification of liability-classified warrants		(1,834)																			(1,834)
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		(394)																			(394)
Stock based compensation		220																			220
Shares, ending balance (in shares) at Oct. 15, 2023	[1]											11,422,476,000
Ending balance at Oct. 15, 2023		(128,578)										$ 1									543							(129,122)
Increase (Decrease) in Temporary Equity
Accretion of Cumulative Dividends		$ 350
Conversion of redeemable convertible preferred stock to common stock in connection with the reverse recapitalization (in shares)	[1]	(20,989,710,000)
Conversion of redeemable convertible preferred stock to common stock in connection with the reverse recapitalization		$ (74,734)
Ending balance (in shares) at Jan. 07, 2024	[1]	0
Ending balance at Jan. 07, 2024		$ 0								$ 0	$ 0
Increase (Decrease) in Stockholders' Equity
Net (loss) income		12,248																										12,248
Issuance of warrants		0	$ 24,592																		23	$ 24,592						(23)
Reclassification of liability-classified warrants		940																			940
Exercise of stock options (in shares)	[1]											45,322,000
Exercise of warrants (in shares)	[1]											296,053,000		655,213,000	924,304,000					20,989,710,000
Exercise of warrants		2,203		$ 5,000	$ 890				$ 74,734											$ 2	2,203		$ 5,000	$ 890			$ 74,732
Conversion of cumulative unpaid dividends on Series I redeemable convertible preferred stock to common stock in connection with the reverse recapitalization (in shares)	[1]											87,755,000
Conversion of cumulative unpaid dividends on Series I redeemable convertible preferred stock to common stock in connection with the reverse recapitalization		878																			878
Accretion of cumulative dividends on Series I redeemable convertible preferred stock		(350)																			(350)
Issuance of common stock in the reverse recapitalization pursuant to the BCA (in shares)	[1]											5,447,203,000
Issuance of common stock in the reverse recapitalization pursuant to the BCA		0										$ 1									(1)
Transfer of warrants related to business combination		(29,824)																			(29,824)
Transaction costs incurred in connection with the reverse recapitalization		(23,362)																			(23,362)
Issuance of common stock as payment for Legacy Pinstripes transaction costs incurred in connection with the reverse recapitalization (in shares)	[1]											50,000,000
Issuance of common stock as settlement for the unpaid accrued interest on the convertible notes (in shares)	[1]											13,749,000
Issuance of common stock as settlement for the unpaid accrued interest on the convertible notes		138																			138
Stock based compensation		$ 254																			254
Shares, ending balance (in shares) at Jan. 07, 2024		39,931,785										39,931,785,000	[1]
Ending balance at Jan. 07, 2024		$ (60,236)										$ 4									$ 56,656							$ (116,896)
Shares, beginning balance (in shares) at Dec. 28, 2023		17,422,009
Shares, ending balance (in shares) at Dec. 29, 2023		39,918,036

[1] The number of shares of Redeemable Convertible Preferred Stock and Common Stock issued and outstanding prior to the Reverse Recapitalization have been retroactively adjusted by the Exchange Ratios to give effect to the Reverse Recapitalization. See Note 2.